Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 198.24
+1.24 (0.63%)
Feb 26, 2026, 3:49 PM AEST
Cochlear Market Cap
Cochlear has a market cap or net worth of 12.88 billion as of February 25, 2026. Its market cap has decreased by -35.34% in one year.
Market Cap
12.88B
Enterprise Value
12.94B
Revenue
2.34B
Ranking
n/a
PE Ratio
37.40
Stock Price
198.24
Market Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 12.88B, an increase of 29,061.94%. That is a compound annual growth rate of 20.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 12.88B | -24.42% |
| Dec 31, 2025 | 17.05B | -10.12% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 2.25B |
| Anteris Technologies Global | 738.96M |
| PolyNovo | 625.21M |
| Aroa Biosurgery | 234.92M |
| Lumos Diagnostics Holdings | 214.17M |
| EMVision Medical Devices | 162.64M |
| SomnoMed | 154.00M |
| Cleo Diagnostics | 74.59M |